Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2022

Lothion-Roy J, Haigh DB, Harris AE, Metzler VM, Alsaleem M, Toss MS, et al. Clinical and molecular significance of the RNA m6A methyltransferase complex in prostate cancer. Front Genet. 2022;13:1096071.

Staats K, Sosa BR, Kuyl E-, Niu Y, Suhardi V, Turajane K, et al. Intermittent parathyroid hormone increases stability and improves osseointegration of initially unstable implants. Bone Joint Res. 2022;11(5):260-269.

Liu J, Westblade LF, Wang F, Chadburn A, Fideli R, Craney A, et al. Distinct Laboratory Test Result Profiles Between SARS-CoV-2 and Seasonable Influenza Infected Patients. Ann Clin Lab Sci. 2022;52(6):871-879.

Boyraz B, Ly A. Discerning subsets of breast cancer with very low and absent HER2 protein expression. Hum Pathol. 2022;127:50-55.

Taylor AS, Liu N, Fang JM, Panarelli N, Zhao L, Cheng J, et al. Cribriform colon cancer: a morphological growth pattern associated with extramural venous invasion, nodal metastases and microsatellite stability. J Clin Pathol. 2022;75(7):483-487.

Velu P, Cong L, Rand S, Qiu Y, Zhang Z, Zhang J, et al. Rapid detection of SARS-CoV-2 variants of concern by single nucleotide polymorphism genotyping using TaqMan assays. Diagn Microbiol Infect Dis. 2022;104(4):115789.

Boyraz B, Watkins JC, Soubeyran I, Bonhomme B, Croce S, Oliva E, et al. Cystic Granulosa Cell Tumors of the Ovary: An Analysis of 80 Cases of an Often Diagnostically Challenging Entity. Arch Pathol Lab Med. 2022;146(12):1450-1459.

Liu Y-, Illar GM, Amri RA, Canady BC, Rea B, Yatsenko SA, et al. Therapy-related myeloid neoplasms with different latencies: a detailed clinicopathologic analysis. Mod Pathol. 2022;35(5):625-631.

Rodino KG, Peaper DR, Kelly BJ, Bushman F, Marques A, Adhikari H, et al. Partial ORF1ab Gene Target Failure with Omicron BA.2.12.1. medRxiv. 2022.

Raman R, Villefranc JA, Ullmann TM, Thiesmeyer J, Anelli V, Yao J, et al. Inhibition of FGF receptor blocks adaptive resistance to RET inhibition in CCDC6-RET-rearranged thyroid cancer. J Exp Med. 2022;219(6).